Rawson, Nigel S B <br/><br/>
Factors associated with celecoxib and rofecoxib utilization.  [electronic resource] 

 -  The Annals of pharmacotherapy  Apr 2005 
 - 597-602 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1060-0280 
<br/><br/><label>Standard No.: </label>10.1345/aph.1E298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Cardiovascular Diseases--chemically induced<br/>Case-Control Studies<br/>Celecoxib<br/>Confidence Intervals<br/>Databases, Factual--statistics & numerical data<br/>Drug Prescriptions--statistics & numerical data<br/>Female<br/>Health Care Sector--statistics & numerical data<br/>Humans<br/>Lactones--adverse effects<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Pyrazoles--adverse effects<br/>Risk Factors<br/>Sulfonamides--adverse effects<br/>Sulfones--adverse effects